Receptor Binding in Drug Discovery and Development

互联网2014-02-10

457

The ultimate goal of any drug development program is the application of basic research, both chemical and biological, to the discovery of therapeutic modalities that can prevent, alleviate, or cure the malfunctions in the mammalian homeostatic mechanism that lead to the disease state.

相关产品推荐

nfsA/nfsA蛋白Recombinant Escherichia coli Oxygen-insensitive NADPH nitroreductase (nfsA)重组蛋白Modulator of drug activity A蛋白

￥2328

YBX1/YBX1蛋白Recombinant Human Y-box-binding protein 1 (YBX1)重组蛋白YB-1;CCAAT-binding transcription factor I subunit A;CBF-A;DNA-binding protein B;DBPB;Enhancer factor I subunit A;EFI-A;Nuclease-sensitive element-binding protein 1;Y-box transcription factor蛋白

￥1836

Tnfrsf17/Tnfrsf17蛋白Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) (Active)重组蛋白B-cell maturation protein (CD_antigen: CD269)蛋白

￥1368

ABCC1抗体ABCC1一抗抗体Multiple drug resistance protein 1 antibody抗体ABCC1 Antibody抗体

￥1100

SUSD6抗体SUSD6兔多抗抗体Drug-activated gene overexpressed protein antibody抗体SUSD6 Antibody, FITC conjugated抗体

￥880